Explore more about: Robotics

FDA approves first-in-human trial for neural-enabled prosthetic hand system developed at FIU.

Researchers have developed nanorobotic agents that can navigate through the bloodstream to administer a drug by targeting the active cancerous cells of tumors.

The U.S. Food and Drug Administration (FDA) has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.